The Impact of GlaxoSmithKline’s Price Increases for Benlysta on Pharmaceutical Innovation
<p>The pharmaceutical industry has long argued that high drug prices are a good thing because the profits from these price hikes allow companies to spend more on research and development to discover and launch the cures of the future.</p>
<p>To test the claim that higher drug prices drive innovation, we gathered data from the industry, individual companies, and the FDA to conduct a counterfactual analysis: what would happen at some of the largest pharmaceutical companies in the world if prices on certain blockbuster drugs had remained constant over the last 10 years?</p>
<p><a href="https://freopp.org/the-impact-of-glaxosmithklines-price-increases-for-benlysta-on-pharmaceutical-innovation-c962c057e792">Website</a></p>
<p> </p>